Instil Bio Inc. (TIL) Appoints John Maraganore to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Instil Bio Inc. (TIL) Appoints John Maraganore to its Board

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

June 11, 2025 7:00 AM EDT

DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Instil) (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today announced the addition of John Maraganore, Ph.D., to the Board of Directors of Axion Bio, Inc., Instils wholly-owned subsidiary dedicated to the development of AXN-2510 (2510), a potentially best-in-class PD-L1xVEGF bispecific antibody for solid tumors prioritizing front-line non-small cell lung cancer (NSCLC).

Johns appointment reflects our commitment to assembling world-class leadership to maximize the value of the 2510 program for patients and shareholders, and we have benefited greatly... More